News
Analysts expect Sarepta Therapeutics to report an earnings per share (EPS) of $1.01. The announcement from Sarepta ...
I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The ...
In his first town hall since voting in favor of Donald Trump’s “big, beautiful bill,” Nebraska Representative Mike Flood had ...
4hOpinion
The New Republic on MSNLaura Loomer Is Getting a Taste of Her Own MedicineAs Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...
5h
The New Republic on MSNLaura Loomer’s New Influence Is Already Backfiring on HerAs Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.
From innovation in manufacturing to more-flexible regulation and better communication with payers, much needs to happen to ...
13h
AlterNet on MSN'Hidden hand': MAGA Republicans slam Laura Loomer as a Big Pharma 'plant'Bulwark reporter Will Sommer reports MAGA influencer Laura Loomer is drawing criticism from MAGA members who claim she’s ...
The FDA's top vaccine official is stepping down after just 3 months in a role that upset drug companies, patient groups and some political leaders.
Detailed price information for Cf Industries Holdings (CF-N) from The Globe and Mail including charting and trades.
23h
Raw Story on MSN'A plant!' Far-right turns on MAGA mega influencer after major ousterA far-right influencer close to President Donald Trump faces suspicion from some of her fellow conspiracy theorists, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results